1. Home
  2. EGRX vs PLBY Comparison

EGRX vs PLBY Comparison

Compare EGRX & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EGRX
  • PLBY
  • Stock Information
  • Founded
  • EGRX 2007
  • PLBY 1953
  • Country
  • EGRX United States
  • PLBY United States
  • Employees
  • EGRX N/A
  • PLBY N/A
  • Industry
  • EGRX Biotechnology: Pharmaceutical Preparations
  • PLBY Recreational Games/Products/Toys
  • Sector
  • EGRX Health Care
  • PLBY Consumer Discretionary
  • Exchange
  • EGRX Nasdaq
  • PLBY Nasdaq
  • Market Cap
  • EGRX 50.7M
  • PLBY 53.2M
  • IPO Year
  • EGRX 2014
  • PLBY N/A
  • Fundamental
  • Price
  • EGRX $1.99
  • PLBY $0.72
  • Analyst Decision
  • EGRX
  • PLBY Buy
  • Analyst Count
  • EGRX 0
  • PLBY 2
  • Target Price
  • EGRX N/A
  • PLBY $2.35
  • AVG Volume (30 Days)
  • EGRX 321.6K
  • PLBY 258.3K
  • Earning Date
  • EGRX 11-12-2024
  • PLBY 11-07-2024
  • Dividend Yield
  • EGRX N/A
  • PLBY N/A
  • EPS Growth
  • EGRX N/A
  • PLBY N/A
  • EPS
  • EGRX 0.91
  • PLBY N/A
  • Revenue
  • EGRX $257,551,000.00
  • PLBY $125,850,000.00
  • Revenue This Year
  • EGRX N/A
  • PLBY N/A
  • Revenue Next Year
  • EGRX N/A
  • PLBY N/A
  • P/E Ratio
  • EGRX $2.35
  • PLBY N/A
  • Revenue Growth
  • EGRX N/A
  • PLBY N/A
  • 52 Week Low
  • EGRX $1.80
  • PLBY $0.43
  • 52 Week High
  • EGRX $14.78
  • PLBY $1.55
  • Technical
  • Relative Strength Index (RSI)
  • EGRX 19.60
  • PLBY 53.39
  • Support Level
  • EGRX $1.80
  • PLBY $0.66
  • Resistance Level
  • EGRX $4.11
  • PLBY $0.77
  • Average True Range (ATR)
  • EGRX 0.40
  • PLBY 0.06
  • MACD
  • EGRX -0.19
  • PLBY -0.00
  • Stochastic Oscillator
  • EGRX 6.86
  • PLBY 41.43

About EGRX Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

About PLBY PLBY Group Inc.

PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

Share on Social Networks: